Cita APA

Wang, Y., Chang, Y., Chen, L., Xu, L., Bian, Z., Zhang, X., . . . Huang, X. (2017). Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes. Oncoimmunology.

Citación estilo Chicago

Wang, Yu, Ying-Jun Chang, Lu Chen, Lan-Ping Xu, Zhi-Lei Bian, Xiao-Hui Zhang, Chen-Hua Yan, Kai-Yan Liu, y Xiao-Jun Huang. "Low-dose Post-transplant Cyclophosphamide Can Mitigate GVHD and Enhance the G-CSF/ATG Induced GVHD Protective Activity and Improve Haploidentical Transplant Outcomes." Oncoimmunology 2017.

Cita MLA

Wang, Yu, et al. "Low-dose Post-transplant Cyclophosphamide Can Mitigate GVHD and Enhance the G-CSF/ATG Induced GVHD Protective Activity and Improve Haploidentical Transplant Outcomes." Oncoimmunology 2017.